z-logo
open-access-imgOpen Access
The use of erector spinae versus transversus abdominis blocks in ovarian surgery: A randomized, comparative study
Author(s) -
Sherif Abdullah Mohamed,
Nirvana Ahmed Elshalakany,
Yousr Farrag,
Sayed M Abed
Publication year - 2022
Publication title -
colombian journal of anesthesiology/revista colombiana de anestesiología/revista colombiana de anestesiologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 9
eISSN - 2145-4604
pISSN - 0120-3347
DOI - 10.5554/22562087.e1025
Subject(s) - medicine , anesthesia , tramadol , visual analogue scale , analgesic , fentanyl , randomized controlled trial , adverse effect , double blind study , rectus sheath , surgery , double blind , abdominal wall , alternative medicine , pathology , placebo
Inadequate pain control after major surgery can lead to significant complications. Ultrasound (US) guided plane blocks account for significant progress in regional anesthesia. Objectives: This study explored the analgesic superiority of ultrasound-guided erector spinae (ESPB) and transversus abdominis (TAPB) plane blocks in patients undergoing major ovarian cancer surgery under general anesthesia. There have been no previous studies comparing their efficacy under these circumstances. Methods: This double-blind randomized comparative study included 60 patients undergoing major ovarian cancer surgery under general anesthesia. The ESPB group (n=30), received preoperative ultrasound-guided ESPB and the TAPB group (n=30), received preoperative low TAPB. Opioid consumption, HR, MAP, visual analogue scale (VAS) and adverse events were documented over 24 hours after surgery. Results: There was a highly significant difference in tramadol consumption between the two groups, with (95% CI: 16.23 to 50.43) and (95% CI: 59.23 to 95.43) for ESPB and TAPB groups, respectively. A significant difference (P < 0.01) was shown in intraoperative fentanyl consumption with (95% CI: 113 to 135.6) and (95% CI: 141.8 to 167.6) for ESPB and TAPB groups, respectively. A highly significant longer time to first analgesic request was recorded in the ESPB group (95% CI: 5.5 -15.3) (P < 0.001). VAS had a median of 2 (1-3) and 4 (2-6) for ESPB and TAPB groups, respectively, with F(1)=18.15, P=0.001 between groups. Postoperative HR and MAP in the TAPB group were significantly higher with more incidence of PONV. Conclusions: ESPB provided a more reliable analgesia versus TAPB in patients undergoing ovarian cancer surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here